CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		1,647,555,590
Beginning balance at Dec. 31, 2021	$ 3,909,355	$ 165	$ 9,995,778	$ (20,716)	$ 0	$ (6,065,872)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(81,286)					(81,286)
Net unrealized gains on investments, net of tax	0
Tax withholding payments for net settlement of employee awards	(182,265)		(182,265)
Issuance of common stock upon vesting of employee RSUs (in shares)		7,081,008
Issuance of common stock upon vesting of employee RSUs	0	$ 1	(1)
Issuance of common stock upon exercise of stock options (in shares)		12,103,110
Issuance of common stock upon exercise of stock options	9,114	$ 1	9,113
Stock-based compensation	174,551		174,551
Ending balance (in shares) at Mar. 31, 2022		1,666,739,708
Ending balance at Mar. 31, 2022	$ 3,829,469	$ 167	9,997,176	(20,716)	0	(6,147,158)
Beginning balance (in shares) at Dec. 31, 2022	1,829,314,736	1,829,314,736
Beginning balance at Dec. 31, 2022	$ 4,349,701	$ 183	11,752,138	(20,716)	(11,572)	(7,370,332)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(779,528)					(779,528)
Net unrealized gains on investments, net of tax	4,035				4,035
Tax withholding payments for net settlement of employee awards	(6,499)		(6,499)
Issuance of common stock upon vesting of employee RSUs (in shares)		1,870,073
Issuance of common stock upon vesting of employee RSUs	$ 0
Issuance of common stock upon exercise of stock options (in shares)	2,200,365	2,200,365
Issuance of common stock upon exercise of stock options	$ 2,181		2,181
Stock-based compensation	$ 61,961		61,961
Ending balance (in shares) at Mar. 31, 2023	1,833,385,174	1,833,385,174
Ending balance at Mar. 31, 2023	$ 3,631,851	$ 183	$ 11,809,781	$ (20,716)	$ (7,537)	$ (8,149,860)